STOCK TITAN

Cardinal Health, Inc. - CAH STOCK NEWS

Welcome to our dedicated page for Cardinal Health news (Ticker: CAH), a resource for investors and traders seeking the latest updates and insights on Cardinal Health stock.

Cardinal Health, Inc. (NYSE: CAH) is a global leader in integrated healthcare services and products. With nearly 100 years of experience, the company stands as a pillar in the healthcare industry, ranking among the top 25 on the Fortune 500 list. Cardinal Health offers a comprehensive suite of services that cater to hospital systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices worldwide.

Operating through two main segments—Pharmaceuticals and Medical—Cardinal Health provides clinically-proven medical products and pharmaceuticals, alongside cost-effective solutions that enhance supply chain efficiency. The company is a major distributor of branded, generic, and specialty pharmaceutical products to a wide array of clients, including retail chains, independent pharmacies, hospital networks, and healthcare providers.

Recently, Cardinal Health reported strong financial results for Q2 FY2024, with a 12% increase in revenue to $57.4 billion. The company also saw significant growth in both its Pharmaceutical and Medical segments, driven by robust sales of brand and specialty pharmaceuticals, as well as improvements in at-Home Solutions and Global Medical Products and Distribution. CEO Jason Hollar highlighted the company's operational execution and strategic priorities, which include tech-enabled specialty acquisitions and a focus on supply chain resiliency.

Cardinal Health is also committed to sustainability and corporate responsibility. The company recently released its Fiscal 2023 Environmental, Social and Governance (ESG) Report, emphasizing long-term value creation through sustainable practices. The company has received approval from the Science Based Targets initiative (SBTi) for its ambitious greenhouse gas (GHG) emissions reduction targets. By FY2023, Cardinal Health had already reduced its Scope 1 and 2 emissions by 13% from a FY2019 base year.

In terms of infrastructure, Cardinal Health is expanding its logistics capabilities. The company has commenced construction on a new 350,000 square-foot Consumer Health Logistics Center in Columbus, Ohio, designed to support the distribution of over-the-counter consumer health products. This facility, expected to be operational by Summer 2025, will create approximately 100 new jobs and enhance Cardinal Health's supply chain agility.

Despite challenges such as the non-renewal of its pharmaceutical distribution contracts with OptumRx, Cardinal Health remains resilient. The company reaffirmed its fiscal 2024 non-GAAP diluted EPS guidance and is confident in its long-term growth targets.

For more information, visit cardinalhealth.com and follow @cardinalhealth on Twitter.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.52%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.47%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.2%
Tags
partnership acquisition
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.19%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.4%
Tags
management dividends
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.99%
Tags
Rhea-AI Summary

Cardinal Health (NYSE: CAH) has launched the innovative Stray Away™ hair management drape, aimed at improving surgical preparation for craniofacial and neurosurgical procedures. This first-of-its-kind product, developed in collaboration with MedStar Health, minimizes hair interference during surgery, enhancing patient experience and operational efficiency. The drape features three unique anchoring points and is designed to secure hair safely while maintaining sterility. The initiative reflects a commitment to addressing patient needs and streamlining surgical processes. Kelley Moffett from Cardinal Health emphasized the solution’s potential to save time for surgical teams, while Marck-Arthur Clerveau of MedStar Health lauded the collaboration as a significant advancement in medical technology.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.58%
Tags
none
-
Rhea-AI Summary

On April 17, 2023, Cardinal Health (NYSE: CAH) announced the opening of two new distribution centers in Central Ohio, marking a significant investment in its Medical Segment. These facilities, located in Groveport and Grove City, span over 782,000 square feet and are designed to support the company's U.S. Medical Products and Distribution (USMPD) and at-Home Solutions businesses. This expansion is part of Cardinal Health's multi-year warehousing modernization plan, aimed at improving service and creating jobs in the local economy. Equipped with advanced warehousing management technology, including robotics and automated fulfillment systems, the centers will enhance operational efficiency while bolstering the company's distribution network.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.71%
Tags
none
-
Rhea-AI Summary

Cardinal Health (NYSE: CAH) will announce its third-quarter financial results for fiscal year 2023 on May 4, prior to market opening. An accompanying webcast discussing these results is scheduled for 8:30 a.m. Eastern. The company, a global distributor of pharmaceuticals and medical products, operates in over 30 countries with approximately 46,500 employees. It has a robust online platform for investor relations where the webcast and presentation slides will be available for 12 months.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.01%
Tags
Rhea-AI Summary

Swisslog announced that Cardinal Health (NYSE: CAH) will implement its AutoStore solution at a new distribution center in Grove City, Ohio. This initiative aims to boost warehouse capacity amid rapid growth in Cardinal Health's at-Home Solutions division. The AutoStore system features 31,844 storage bins, enabling efficient management of 14,154 SKUs, ultimately enhancing speed and reducing human error in order fulfillment. This marks Cardinal Health's first use of AutoStore, reflecting a commitment to modernizing operations and addressing labor shortages. The collaboration emphasizes optimizing supply chain resilience and enhancing customer service.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.99%
Tags
none

FAQ

What is the current stock price of Cardinal Health (CAH)?

The current stock price of Cardinal Health (CAH) is $120.03 as of November 18, 2024.

What is the market cap of Cardinal Health (CAH)?

The market cap of Cardinal Health (CAH) is approximately 29.2B.

What services does Cardinal Health offer?

Cardinal Health provides integrated healthcare services and products, including clinically-proven medical products, pharmaceuticals, and supply chain solutions for hospital systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices.

How did Cardinal Health perform in Q2 FY2024?

Cardinal Health reported a 12% increase in revenue to $57.4 billion, with strong growth in both Pharmaceutical and Medical segments. Non-GAAP diluted EPS increased 38% to $1.82.

What is Cardinal Health's approach to sustainability?

Cardinal Health is committed to sustainability and corporate responsibility, as evidenced by its Fiscal 2023 ESG Report and approval from the Science Based Targets initiative (SBTi) for its greenhouse gas (GHG) emissions reduction targets.

What are Cardinal Health's main business segments?

Cardinal Health operates through two main segments: Pharmaceuticals and Medical. The Pharmaceuticals segment focuses on the distribution of branded, generic, and specialty pharmaceutical products, while the Medical segment provides medical-surgical products and equipment.

What recent infrastructure developments has Cardinal Health announced?

Cardinal Health has begun construction on a 350,000 square-foot Consumer Health Logistics Center in Columbus, Ohio, scheduled to be operational by Summer 2025. This facility will support the distribution of over-the-counter consumer health products.

How many employees does Cardinal Health have?

Cardinal Health employs more than 48,000 people globally, with operations in over 30 countries.

What are Cardinal Health's fiscal 2024 guidance and expectations?

Cardinal Health raised its fiscal 2024 guidance range for non-GAAP diluted earnings per share to $7.30 to $7.40. The company also expects 8.5% to 9.5% growth in Pharmaceutical and Specialty Solutions segment profit.

How is Cardinal Health addressing supply chain efficiency?

Cardinal Health continuously works on enhancing supply chain efficiency through advanced inventory management systems and supply chain resiliency initiatives. The new Consumer Health Logistics Center will further improve its capabilities.

What impact will the non-renewal of OptumRx contracts have on Cardinal Health?

Despite the non-renewal of its contracts with OptumRx, Cardinal Health expects to partially offset the impact through new customer wins, specialty growth, and other actions. The company has reaffirmed its long-term growth targets.

Where can I find more information about Cardinal Health?

More information about Cardinal Health is available on its website at cardinalhealth.com. You can also follow the company on Twitter @cardinalhealth.

Cardinal Health, Inc.

NYSE:CAH

CAH Rankings

CAH Stock Data

29.16B
241.33M
0.25%
89.58%
2.27%
Medical Distribution
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States of America
DUBLIN